- Global Pharma News & Resources
14-May-2019 - 15-May-2019

Annual Bioprocessing & Industrial Biotechnology Congress

3rd Annual Bioprocessing and Industrial Biotechnology Congress commences from October 14-15, 2019 at one of the most attractive city of the world, Brussels, Belgium.

Bioprocess 2019 aims to bring together the professors, researchers, scientists, business giants, and technocrats to provide an international forum for the dissemination of original research results, new ideas and practical development and discover advances in the field of biotechnology, management and education in relation to biotechnology as well as a breadth of other topics. The applications of biotechnology include therapeutics, diagnostics, and genetically modified crops for agriculture, processed food, bioremediation, waste treatment, and energy production. Bioprocess Meeting is an excellent opportunity for the delegates from universities and institutes to interact with the world class scientists.

Biotechnology Congress creates a platform for scientists, representatives and decision makers in biotechnology to share and learn new things.

Submit your research abstract under any session of your interest:

1. Biomaterials & Biocomposites: Biomaterials are those materials engineered to interact with biological systems for medical purpose to augment or replace a natural function. Study of biomaterials is called biomaterials science or biomaterials engineering. Many companies invest huge amounts of money for the development of new products. It holds within elements of medicine, biology, chemistry, tissue engineering and materials science.

2. Biopharmaceutical Products: A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy.

3. Cell Therapy & Processing: Mesenchymal stromal cells (MSC) are multipotent stem cells that have been isolated from tissues and are currently being used to demonstrate their therapeutic efficacy against various clinical indications. Dramatic increase in the use of MSCs for tissue engineering applications and in regenerative medicine in past two decades raises an increasing demand for cGMP (current Good Manufacturing Practice) based large-scale manufacturing process of MSCs and characterization of these cells. Cell therapy bio-processing involves the usage of numerous in-put materials to produce a complex and viable stem cell product. Therefore, developing a unique bio-processing model with novel production process is challenging for the nascent cell therapy manufacturing industries and requires utilizing bioprocessing experiences and solutions for the progressing towards GMP compliance large-scale MSC production.


5. Fermentation & Bioprocessing: Certain organisms perform fermentation to obtain energy they need to carry on their life processes. Many of the fermentation processes result in products like enzymes that are important in medicine, food preparation, and other fields. Fermentation has two parts: upstream and downstream. The upstream part of a bioprocess refers to the first step in which microbes/cells are grown, e.g. bacterial or mammalian cell lines (see cell culture), in bioreactors. After product development, the next step is the purification of product for desired quality, which is done in downstream processing.

6. Food technology & processing: The functional foods market represents one of the fastest growing and most fascinating areas of investigation and innovation in the food sector. There are various recent findings, new research trends, and emerging technologies in bioprocessing focusing on use of microorganisms in the production of food with health and nutritional benefits. There are emerging applications of microorganisms in safe food production, which is part of microbial bioprocessing.

7. Biofuels & Biorefinery: Advanced biofuels are fuels that can be processed from numerous types of biomass. First generation biofuels are processed from the sugars and vegetable oils formed in arable crops, which can be smoothly extracted applying conventional technology. Biorefining is the efficient processing of biomass into a wide range of marketable products and energy. By producing multiple products; a biorefinery can take advantage of the differences in biomass components and intermediates and maximize the value derived from the biomass feedstock.

8. Plant Biotechnology: Plant Biotechnology is a set of techniques used to adapt plants for specific needs or opportunities. Plant Biotechnology applies technological methods to biological organisms. It can also be defined as the introduction of desirable traits into plants through genetic modification.

9. Agricultural Biotechnology & Agro-forestry: Agricultural biotechnology is a collection of scientific techniques used to improve plants, animals and microorganisms. Agroforestry is an activity that combines production on the same plot of land, from annual agricultural activities (such as crops and pasture) and from delayed long-term production by trees.


11. Bioeconomy: The bioeconomy is an economy using biological resources from the land and sea, as well as waste, as inputs to food and feed, industrial and energy production. It also covers the use of bio-based processes for sustainable industries. Bio-waste for example has considerable potential as an alternative to chemical fertilizers or for conversion into bio-energy, and can meet 2% of the EU renewable energy target. In Europe today the bioeconomy is already worth more than 2 trillion euros annually and employs over 22 million people (9% of the total). It includes primary production, such as agriculture, forestry, fisheries and aquaculture, and industries using/ processing biological resources, such as the food and pulp and paper industries and parts of the chemical, biotechnological and energy industries. Each euro invested in EU-funded bioeconomy research and innovation in 2012 is estimated to trigger 10 euros of value added in bioeconomy sectors by 2025.